Sterling Biotech (Delisted) share price
BSE: 512299Pharmaceuticals & Biotechnology
Sterling Biotech Ltd. · Formerly Sterling Tea and Industries · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1986
Last traded ₹0.70 on 5 Nov 2018
Delisted on 3 Mar 2023.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.
Feb 2023
24 Feb · Delisting
Members of the Exchange are hereby informed that the admission to dealings in securities of the company Sterling Biotech Limited shall be withdrawn (delisted) w.e.f. March 03, 2023 pursuant to Hon ble National Company Law Tribunal (NCLT) order dated November 11, 2022.
Nov 2022
15 Nov · Liquidation
14 Nov · Intimation Of Liquidation Process As Per The Requirement Of Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
4 Nov · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 2 2 0
Oct 2022
12 Oct · Audited Financial Statement For The Financial Year 2021-22
Jul 2022
20 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Results for the quarter to Mar 2019
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
- RevenueRevenue from operations. Money earned from selling the company's goods and services in the period. Revenue from operations in the glossary
- ₹89 Cr−6.3% on the quarter beforeChange on a year ago and on the quarter before. The change against the same quarter a year before: (this quarter's figure less that quarter's) divided by that quarter's, times 100. The change on the quarter before is the same sum against the quarter just before, taken as this quarter's results restate it where the company restated it: this quarter's year to date less this quarter. Left out where either figure is a loss, where the restatement covers two or more earlier quarters without saying which, or across a change of basis named under the table, on the lines it affects.
- Operating profitOperating profit before depreciation (EBITDA). Revenue less operating expenses: what the business earns from its operations before depreciation, interest and tax. Operating profit before depreciation (EBITDA) in the glossary
- ₹16 Cr+45.3% on the quarter before
- Net profitNet profit. What is left of revenue and other income after every cost, interest and tax. Net profit in the glossary
- −₹922 Cr
- Operating margin
- 18.5%
- Net margin
- −1,036.3%
From revenue to net profit, ₹ crore
- Revenue89
- Materials and goods−55
- Employee costs−11
- Other expenses−6.0
- Operating profit16
- Depreciation−61
- Other income−2.1
- One-off items0.0
- Finance costs+24
- Profit before tax−23
- Tax−899
- Net profit−922
Sterling Biotech results by quarter
Standalone: the listed company alone, without its subsidiaries. Latest quarter to Mar 2019. Results for the quarter to Jun 2019 were due by 14 Aug 2019, 45 days after it ends. Every company's dates are on the results calendar.
Revenue and net profit by quarter, ₹ crore
- Revenue
- Net profit
- Loss
Peak revenue ₹105 Cr, quarter to Dec 2016; lowest ₹82 Cr, quarter to Sep 2018A loss in the quarter to Mar 2019, −₹922 Cr
Operating and net margin by quarter, per cent
- Operating margin
- Net margin
| ₹ crore | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018Q1 | Sep 2018 | Dec 2018Q3 | Mar 2019worked out |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 186 | 174 | 122 | 102 | 118 | 108 | 87 | 116 | 104 | 95 | 105 | 100what Revenue from operations, Mar 2017, includes. This period's revenue includes excise duty of ₹7.89 crore, a tax on the goods the company makes that it collects and pays to the government. | 101 | – | – | – | 84 | 82 | 95 | 89what Revenue from operations, Mar 2019, includes. Not filed on its own: worked out as the year to Mar 2019 the company filed, less the nine months to Dec 2018. |
| Operating expenses. What the business spent to run itself in the period, materials, staff and other costs, before depreciation, interest and tax. Operating expenses in the glossary | 148 | 146 | 110 | 89 | 97 | 93 | 82 | 99 | 92 | 102 | 100 | 94 | 100 | – | – | – | 80 | 70 | 84 | 72 |
| Materials and goods boughtCost of materials and goods. Raw materials used and goods bought for resale in the period, adjusted for the change in stock held. Cost of materials and goods in the glossary | 126 | 125 | 88 | 68 | 76 | 73 | 60 | 78 | 64 | 75 | 71 | 63 | 72 | – | – | – | 61 | 52 | 65 | 55 |
| Employee costsEmployee costs. Salaries, wages, bonuses and other benefits paid to staff in the period. Employee costs in the glossary | 13 | 13 | 12 | 12 | 13 | 13 | 14 | 14 | – | – | – | – | – | – | – | – | 13 | 12 | 13 | 11 |
| Other expensesOther expenses. Every operating cost besides materials and staff: power, rent, freight, repairs, marketing and the like. Other expenses in the glossary | 9 | 9 | 9 | 9 | 7 | 7 | 8 | 8 | – | – | – | – | – | – | – | – | 6 | 6 | 6 | 6 |
| Operating profit before depreciation | 38 | 28 | 12 | 13 | 21 | 15 | 6 | 17 | 12 | −6 | 5 | 6 | 0 | – | – | – | 4 | 12 | 11 | 16 |
| Operating margin | 20.4% | 16.0% | 10.2% | 12.9% | 18.1% | 13.8% | 6.6% | 14.8% | 11.5% | −6.8% | 5.0% | 5.9% | 0.5% | – | – | – | 4.5% | 15.1% | 11.9% | 18.5% |
| Depreciation and amortisationDepreciation and amortisation. The part of the cost of plant, buildings and other long-lived assets charged against each year they are used. Depreciation and amortisation in the glossary | 64 | 64 | 85 | 70 | 70 | 70 | 70 | 70 | 66 | 66 | 66 | 66 | 67 | – | – | – | 61 | 61 | 61 | 61 |
| Other incomeOther income. Income from outside the main business, such as interest on deposits, dividends received and gains on investments. Other income in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | 1 | – | – | – | 2 | 2 | 1 | −2 |
| Finance costsFinance costs. Interest and the other costs of borrowing in the period. Finance costs in the glossary | 128 | 129 | 88 | 76 | 82 | 84 | 89 | 83 | 80 | 95 | 97 | 98 | 103 | – | – | – | 237 | 148 | −102 | −24 |
| Profit before one-off items and taxProfit before one-off items and tax. Profit before tax as it would be without the one-off items below it, as the company states it. Profit before one-off items and tax in the glossary | −154 | −165 | −160 | −134 | −131 | −139 | −154 | −136 | −134 | −167 | −158 | −158 | −167 | – | – | – | −293 | −195 | 53 | −23 |
| One-off itemsExceptional items. Gains or losses the company reports separately because they are not expected to recur, such as selling a business or writing down an asset. Exceptional items in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | −3,010 | 0 | 0 | 0 |
| Profit before tax | −154 | −165 | −160 | −134 | −131 | −139 | −154 | −136 | −134 | −167 | −158 | −158 | −167 | – | – | – | −3,303 | −195 | 53 | −23 |
| −50 | −53 | −52 | −43 | −43 | −45 | −50 | −44 | −46 | −58 | −55 | −45 | −58 | – | – | – | −994 | −59 | 16 | 899 | |
| Tax rateEffective tax rate. Tax charged as a percentage of profit before tax. Effective tax rate in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 30.1% | – |
| Net profit | −110 | −117 | −127 | −90 | −88 | −94 | −104 | −92 | −88 | −110 | −103 | −112 | −110 | – | – | – | −2,309 | −136 | 37 | −922 |
| Other comprehensive incomeOther comprehensive income. Gains and losses booked straight to net worth rather than through profit, such as changes in the value of some investments, pension plans and currency translation. Other comprehensive income in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | −1,420 | 0 | 0 | – |
| Total comprehensive incomeTotal comprehensive income. Net profit plus other comprehensive income. Total comprehensive income in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | −3,729 | −136 | 37 | – |
| Net margin | −59.4% | −67.2% | −104.1% | −88.5% | −74.9% | −87.2% | −118.7% | −79.0% | −84.2% | −114.9% | −98.2% | −112.4% | −108.5% | – | – | – | −2,759.9% | −166.1% | 38.9% | −1,036.3% |
| Earnings per shareEarnings per share. Profit belonging to shareholders divided by the number of shares, restated for later splits and bonuses so they do not break the line. Earnings per share in the glossary | −₹4.11 | −₹4.29 | −₹4.68 | −₹3.32 | −₹3.25 | −₹3.46 | −₹3.82 | −₹3.37 | −₹3.22 | −₹4.02 | −₹3.79 | −₹4.12 | −₹4.02 | – | – | – | −₹137.02 | −₹5.01 | ₹1.36 | – |
| Diluted earnings per shareDiluted earnings per share. Earnings per share counting the shares that options, warrants and convertible bonds already granted would add, on today's share count after splits and bonuses. Diluted earnings per share in the glossary | −₹2.55 | −₹2.70 | −₹2.94 | −₹2.09 | −₹2.04 | −₹2.18 | −₹2.40 | −₹2.12 | −₹2.02 | −₹2.53 | −₹2.38 | −₹2.59 | −₹2.53 | – | – | – | −₹137.02 | −₹5.01 | ₹0.86 | – |
Earnings per share in rupees, restated for later splits and bonuses. No results on record for the quarters to Sep 2017, Dec 2017 and Mar 2018.
10 years at a glance
Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to December, then March.
Revenue, net profit and borrowings, ₹ crore
- Revenue
- Net profit
- Borrowings
- Loss
A loss in 7 of the 8 years with results on record
Operating and net margin, per cent
- Operating marginOperating margin. Operating profit before depreciation as a percentage of revenue: how much of each rupee of sales is left after running costs. Operating margin in the glossary
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
The company moved its year end from December to March: its last year to December on record ended in Dec 2014, its first year to March in Mar 2017.
The years either side of a change of basis do not compare. From the year to Mar 2019, GST replaced excise duty on 1 Jul 2017, and revenue before that day includes the duty.
Results for the year to Mar 2021
Standalone: the listed company alone, without its subsidiaries. ₹ crore.
From revenue to net profit
- Revenue343
- Materials and goods−234
- Employee costs−41
- Other expenses−30
- Operating profit38
- Depreciation−245
- Other income+75
- Finance costs−0.2
- Profit before tax−133
- Tax−711
- Net profit−844
Profit and loss
Standalone, ₹ crore, years to December, then March. No results on record for the years to Mar 2016 and Mar 2018.
| ₹ crore | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 1,671 | 842 | 722 | 671 | – | 404what Revenue from operations, Mar 2017, includes. This period's revenue includes excise duty of ₹32 crore, a tax on the goods the company makes that it collects and pays to the government. | – | 350 | 346 | 343 |
| 1,025 | 687 | – | 556 | – | 388 | – | 306 | 536 | 305 | |
| Materials and goods bought | 880 | 581 | 512 | 466 | – | 273 | – | 232 | 233 | 234 |
| Employee costs | 51 | 54 | – | 52 | – | – | – | 49 | 49 | 41 |
| Other expenses | 94 | 53 | – | 39 | – | – | – | 24 | 255 | 30 |
| Operating profit before depreciation | 646 | 155 | – | 115 | – | 17 | – | 44 | −190 | 38 |
| Operating margin | 38.7% | 18.4% | – | 17.1% | – | 4.1% | – | 12.6% | −55.1% | 11.0% |
| Materials, % of revenueMaterials, % of revenue. Raw materials used and goods bought for resale, adjusted for the change in stock, divided by revenue, times 100. Materials, % of revenue in the glossary | 52.7% | 69.0% | – | 69.4% | – | – | – | 66.5% | 67.3% | 68.2% |
| Employee costs, % of revenueEmployee costs, % of revenue. Salaries, wages and other staff costs divided by revenue, times 100. Employee costs, % of revenue in the glossary | 3.0% | 6.4% | – | 7.7% | – | – | – | 14.1% | 14.1% | 12.0% |
| Other expenses, % of revenueOther expenses, % of revenue. Operating costs besides materials and staff divided by revenue, times 100; with the two above and the operating margin it makes 100. Other expenses, % of revenue in the glossary | 5.6% | 6.2% | – | 5.7% | – | – | – | 6.8% | 73.7% | 8.8% |
| Depreciation and amortisation | 251 | 260 | – | 277 | – | 264 | – | 246 | 246 | 245 |
| Operating profit after depreciationOperating profit after depreciation (EBIT). Operating profit before depreciation, less depreciation and amortisation. Operating profit after depreciation (EBIT) in the glossary | 395 | −105 | – | −162 | – | −247 | – | −202 | −436 | −207 |
| Other income | – | – | – | – | – | – | – | 2 | 4 | 75 |
| Finance costs | 270 | 412 | 438 | 470 | – | 370 | – | 259 | 0 | 0 |
| Profit before one-off items and tax | 125 | −518 | −593 | −631 | – | −617 | – | −458 | −432 | −133 |
| One-off items | – | – | – | – | – | – | – | −3,010 | – | – |
| Profit before tax | 125 | −518 | −593 | −631 | – | −617 | – | −3,468 | −432 | −133 |
| 9 | −168 | −192 | −205 | – | −204 | – | −138 | – | 711 | |
| Net profit | 19 | −350 | −401 | −458 | – | −412 | – | −3,330 | −432 | −844 |
| Net margin | 1.1% | −41.6% | −55.5% | −68.2% | – | −102.1% | – | −952.8% | −125.1% | −246.2% |
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2017 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Dec 2013: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.
Earlier years, Dec 2007 to Dec 2010
| ₹ crore | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 |
|---|---|---|---|---|
| Revenue from operations | 911 | 1,188 | 1,447 | 1,627 |
| 502 | 677 | 933 | 919 | |
| Materials and goods bought | 316 | 425 | 606 | 801 |
| Employee costs | 24 | 35 | 40 | 44 |
| Other expenses | 162 | 217 | 286 | 75 |
| Operating profit before depreciation | 409 | 511 | 514 | 708 |
| Operating margin | 44.9% | 43.0% | 35.5% | 43.5% |
| Materials, % of revenue | 34.7% | 35.7% | 41.9% | 49.2% |
| Employee costs, % of revenue | 2.7% | 3.0% | 2.8% | 2.7% |
| Other expenses, % of revenue | 17.8% | 18.3% | 19.8% | 4.6% |
| Depreciation and amortisation | 86 | 107 | 123 | 198 |
| Operating profit after depreciation | 322 | 404 | 391 | 510 |
| Other income | 10 | – | – | – |
| Finance costs | 41 | 59 | 149 | 230 |
| Profit before tax | 291 | 345 | 242 | 280 |
| 95 | 113 | 69 | 71 | |
| Net profit | 184 | 219 | 237 | 146 |
| Net margin | 20.2% | 18.4% | 16.4% | 9.0% |
Standalone, ₹ crore, years to December.
Ratios
Standalone, years to December, then March.
| Ratio | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growthRevenue growth. This year's revenue less last year's, divided by last year's, times 100; blank where last year's is not above nought. Revenue growth in the glossary | 2.7% | −49.6% | −14.2% | −7.2% | – | – | – | – | −1.1% | −0.9% |
| Operating profit growthOperating profit growth. This year's operating profit before depreciation less last year's, divided by last year's, times 100; blank where last year's is not above nought. Operating profit growth in the glossary | −8.7% | −76.1% | – | – | – | – | – | – | – | – |
| Net profit growthNet profit growth. This year's net profit less last year's, divided by last year's, times 100; blank where last year's is not above nought. Net profit growth in the glossary | −86.9% | – | – | – | – | – | – | – | – | – |
| Earnings per share growthEarnings per share growth. This year's earnings per share less last year's, on the same share count, divided by last year's, times 100; blank where last year's is not above nought. Earnings per share growth in the glossary | −87.3% | – | – | – | – | – | – | – | – | – |
| Interest coverInterest cover. Operating profit after depreciation divided by finance costs: how many times over the profit pays the interest bill. Interest cover in the glossary | 1.5 | – | – | – | – | – | – | – | – | – |
Interest cover is left blank for the years to Dec 2012, Dec 2014, Mar 2017, Mar 2019, Mar 2020 and Mar 2021: operating profit after depreciation is a loss, and a loss covers no interest bill.
Growth and returns over 3, 5 and 10 years
Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2021.
| Measure | 5 years | 3 years |
|---|---|---|
| Operating margin, averageOperating margin, average. 3 years: The plain average of the yearly operating profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly operating profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly operating profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | −6.9% | −10.5% |
| Net margin, averageNet margin, average. 3 years: The plain average of the yearly net profit margin over the last three years, needing at least two of them; a year without the figure is left out, never filled in. 5 years: The plain average of the yearly net profit margin over the last five years, needing at least four of them; a year without the figure is left out, never filled in. 10 years: The plain average of the yearly net profit margin over the last ten years, needing at least nine of them; a year without the figure is left out, never filled in. | −356.5% | −441.4% |
Accounting checks
Standalone, years to December, then March. Published tests of whether reported profit is backed by cash and the balance sheet.
| Check | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Effective tax ratePublished threshold 17.16 per cent | 7.43 | – | – | – | – | – | – | – | – | – |
A threshold marked as ours has no published figure; it is the line we read the check against.
Business segments
In the quarter to Dec 2018 the company reports one business segment, Manufacture of Chemicals and Chemical Products, which carries all its revenue.
Sterling Biotech share price by year
Each calendar year to 2018.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2018 | 0.70 | −82.1% | 5.10 | 0.65 |
| 2017 | 3.90 | +9.9% | 6.35 | 3.15 |
| 2016 | 3.55 | −51.7% | 7.45 | 3.05 |
| 2015 | 7.35 | +5.8% | 8.20 | 4.55 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2018 close is its last trade, on 5 Nov 2018.
Recent sessions
The 10 trading days to 5 Nov 2018, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 5 Nov 2018 | 0.65 | 0.75 | 0.65 | 0.70 | 0.75 | 16,887 |
| 29 Oct 2018 | 0.65 | 0.70 | 0.60 | 0.70 | 0.65 | 36,738 |
| 22 Oct 2018 | 0.70 | 0.75 | 0.65 | 0.65 | 0.70 | 1,03,815 |
| 15 Oct 2018 | 0.60 | 0.70 | 0.60 | 0.70 | 0.61 | 55,086 |
| 8 Oct 2018 | 0.70 | 0.75 | 0.65 | 0.65 | 0.70 | 1,15,796 |
| 1 Oct 2018 | 0.70 | 0.75 | 0.70 | 0.70 | 0.71 | 24,850 |
| 24 Sep 2018 | 0.80 | 0.80 | 0.75 | 0.75 | 0.75 | 35,056 |
| 17 Sep 2018 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 21,954 |
| 10 Sep 2018 | 0.85 | 0.85 | 0.85 | 0.85 | 0.85 | 5,200 |
| 3 Sep 2018 | 0.90 | 0.90 | 0.90 | 0.90 | 0.90 | 17,320 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 512299
- ISIN
- INE324C01038
- Industry
- Pharmaceuticals & Biotechnology
- Former symbols
- STERLINBIO, STERLINTEA
- Website
- www.sterlingbiotech.in
- CIN
- L51900MH1985PLC035738
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1985
- Registered office
- 43, Atlanta Building, Nariman Point, Mumbai 400021, Maharashtra
- Share registrar
- Link Intime India Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments